Oral administration of succinoglycan riclin improves diet-induced hypercholesterolemia in mice.
Clicks: 331
ID: 64643
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
63.3
/100
331 views
217 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #48 of 850 articles by views in Journal of agricultural and food chemistry
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 850 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Epidemiological studies have demonstrated hypercholesterolemia is associated with an elevated risk of atherosclerosis and cardiovascular diseases. In addition to the available cholesterol-lowering drugs, nutritionally balanced diets containing functional foods have attracted much interests as potential candidates to improve hypercholesterolemia. In the study, we demonstrated that dietary succinoglycan riclin effectively alleviated diet-induced hypercholesterolemia. Compared with high-cholesterol-diet (HCD) group, high riclin group significantly decreased levels of serum total cholesterol, low density lipoprotein cholesterol (LDL-C) and hepatic cholesterol (34%, 40% and 51% respectively), consequently improving hepatic steatosis and reducing pro-inflammatory cytokine expressions. 1H nuclear magnetic resonance (NMR) based lipidomics and metabolomics analyses revealed that riclin group partially reversed metabolic profile changes induced by HCD, approaching to the normal diet (ND) group. Riclin has no direct effects on cholesterol metabolism-related genes expression among three HCD model groups. Basically, riclin increased the solution viscosity and interfered the process of bile acids-cholesterol emulsification, decreasing cholesterol digestion and promoting cholesterol and bile acids excretion in the feces. These results suggested a potential therapeutic utility of succinoglycan riclin as a food additive for people suffering from hypercholesterolemia and related diseases.
| Reference Key |
yang2019oraljournal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Yang, Yunxia;Sun, Qi;Xu, Xi;Yang, Xiao;Gao, Yan;Sun, Xiaqing;Zhao, Yang;Ding, Zhao;Ge, Wenhao;Cheng, Rui;Zhang, Jianfa; |
| Journal | Journal of agricultural and food chemistry |
| Year | 2019 |
| DOI |
10.1021/acs.jafc.9b06034
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.